Brief: Nih Awards Contract To An2 Therapeutics Valued At $17.8 Mln
29/09/2022 12:37
Sept 29 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* NIH AWARDS CONTRACT TO AN2 THERAPEUTICS VALUED UP TO $17.8
MILLION
* AN2 THERAPEUTICS INC - BASE PERIOD CONTRACT IS $4.3
MILLION WITH
ADDITIONAL OPTIONS THAT, IF EXERCISED, WILL TOTAL $17.8 MILLION
Source text for Eikon: ID:nGNX22gv8Y
Further company coverage: ANTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview